CHEBI:7565 - nifedipine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name nifedipine
ChEBI ID CHEBI:7565
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information eMolecules:524652, ZINC000003875336
Download Molfile XML SDF
Wikipedia License
Cocaine (from French cocaïne, from Spanish coca, ultimately from Quechua kúka) is a tropane alkaloid that acts as a central nervous system (CNS) stimulant. As an extract, it is mainly used recreationally and often illegally as a euphoriant and as an aphrodisiac. It is also used in medicine by indigenous South Americans for various purposes and rarely, but more formally, as a local anaesthetic or diagnostic tool by medical practitioners in more developed countries. It is primarily obtained from the leaves of two coca species native to South America: Erythroxylum coca and E. novogranatense. After extraction from the plant, and further processing into cocaine hydrochloride (powdered cocaine), the drug is administered by being either snorted, applied topically to the mouth, or dissolved and injected into a vein. It can also then be turned into free base form (typically crack cocaine), in which it can be heated until sublimated and then the vapours can be inhaled. Cocaine stimulates the mesolimbic pathway in the brain. Mental effects may include an intense feeling of happiness, sexual arousal, loss of contact with reality, or agitation. Physical effects may include a fast heart rate, sweating, and dilated pupils. High doses can result in high blood pressure or high body temperature. Onset of effects can begin within seconds to minutes of use, depending on method of delivery, and can last between five and ninety minutes. As cocaine also has numbing and blood vessel constriction properties, it is occasionally used during surgery on the throat or inside of the nose to control pain, bleeding, and vocal cord spasm. Cocaine crosses the blood–brain barrier via a proton-coupled organic cation antiporter and (to a lesser extent) via passive diffusion across cell membranes. Cocaine blocks the dopamine transporter, inhibiting reuptake of dopamine from the synaptic cleft into the pre-synaptic axon terminal; the higher dopamine levels in the synaptic cleft increase dopamine receptor activation in the post-synaptic neuron, causing euphoria and arousal. Cocaine also blocks the serotonin transporter and norepinephrine transporter, inhibiting reuptake of serotonin and norepinephrine from the synaptic cleft into the pre-synaptic axon terminal and increasing activation of serotonin receptors and norepinephrine receptors in the post-synaptic neuron, contributing to the mental and physical effects of cocaine exposure. A single dose of cocaine induces tolerance to the drug's effects. Repeated use is likely to result in addiction. Addicts who abstain from cocaine may experience prolonged craving lasting for many months. Abstaining addicts also experience modest drug withdrawal symptoms lasting up to 24 hours, with sleep disruption, anxiety, irritability, crashing, depression, decreased libido, decreased ability to feel pleasure, and fatigue being common. Use of cocaine increases the overall risk of death, and intravenous use potentially increases the risk of trauma and infectious diseases such as blood infections and HIV through the use of shared paraphernalia. It also increases risk of stroke, heart attack, cardiac arrhythmia, lung injury (when smoked), and sudden cardiac death. Illicitly sold cocaine can be adulterated with fentanyl, local anesthetics, levamisole, cornstarch, quinine, or sugar, which can result in additional toxicity. In 2017, the Global Burden of Disease study found that cocaine use caused around 7,300 deaths annually.
Read full article at Wikipedia
Formula C17H18N2O6
Net Charge 0
Average Mass 346.33460
Monoisotopic Mass 346.11649
InChI InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3
InChIKey HYIMSNHJOBLJNT-UHFFFAOYSA-N
SMILES COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) See: DOI
Roles Classification
Biological Role(s): calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Application(s): vasodilator agent
A drug used to cause dilation of the blood vessels.
tocolytic agent
Any compound used to suppress premature labour and immature birth by suppressing uterine contractions.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing nifedipine (CHEBI:7565) has role calcium channel blocker (CHEBI:38215)
nifedipine (CHEBI:7565) has role human metabolite (CHEBI:77746)
nifedipine (CHEBI:7565) has role tocolytic agent (CHEBI:66993)
nifedipine (CHEBI:7565) has role vasodilator agent (CHEBI:35620)
nifedipine (CHEBI:7565) is a C-nitro compound (CHEBI:35716)
nifedipine (CHEBI:7565) is a dihydropyridine (CHEBI:50075)
nifedipine (CHEBI:7565) is a methyl ester (CHEBI:25248)
IUPAC Name
dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
INNs Sources
nifedipine ChemIDplus
nifedipino ChemIDplus
nifedipinum ChemIDplus
Synonyms Sources
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester ChemIDplus
Nifedipine KEGG COMPOUND
Brand Names Sources
Adalat DrugBank
Adapine DrugBank
Coracten DrugBank
Nifecard DrugBank
Nifecor DrugBank
Nifedipres DrugBank
Procardia DrugBank
Manual Xrefs Databases
1922 DrugCentral
C07266 KEGG COMPOUND
D00437 KEGG DRUG
DB01115 DrugBank
LSM-4176 LINCS
Nifedipine Wikipedia
View more database links
Registry Numbers Types Sources
21829-25-4 CAS Registry Number KEGG COMPOUND
21829-25-4 CAS Registry Number NIST Chemistry WebBook
21829-25-4 CAS Registry Number ChemIDplus
497773 Beilstein Registry Number Beilstein
Last Modified
09 March 2018